Ukraine-Tested Lendurai Autonomy System Goes Onto Israeli Hero Drones, russia Copied These as Lancet
Defense Express · · 5 min read
This item matters less for the Hero airframe than for the autonomy layer riding on it. Lendurai's Neocortex, combat-validated in Ukraine, is being ported onto a loitering munition already selected under a roughly $982M U.S. Army effort to localize Hero 120 production stateside. That combination — proven autonomy plus domestic manufacturing — is the template the Pentagon wants for attritable strike. It also sharpens the counter-Lancet problem: the same autonomy that makes Hero harder to jam will migrate to adversaries' systems within a procurement cycle or two.
The headline reads like a product announcement: an Estonian autonomy stack finds a home on an Israeli loitering munition. The more useful reading is that the West is quietly standardizing the software layer of attritable strike while it struggles to scale the hardware layer, and that the two are now being deliberately fused inside a U.S. Army program of record.
Start with what Neocortex actually is. Lendurai's pitch is autonomy that survives contested electromagnetic environments — navigation and terminal targeting that do not depend on a clean GNSS fix or a continuous command link. That is precisely the failure mode that has shaped the drone war in Ukraine. Russian and Ukrainian formations alike have learned that the cheapest way to defeat a small drone is not to shoot it down but to sever its datalink or spoof its position, at which point an inexpensive munition becomes an expensive glider. Autonomy — visual or inertial navigation, onboard target recognition, terminal homing without a human in the loop — is the counter. It is also the reason the Estonian firm's combat exposure in Ukraine carries weight: it is not a laboratory claim, it is a fielded claim, and Western buyers have started treating Ukrainian employment as the de facto qualification standard for this class of software.
Now the platform. Uvision's Hero family is a family of loitering munitions — tube-launched, man-portable or vehicle-mounted, designed to orbit, find, and dive on a target. The Hero 120 sits in the middle of that range. The Russian Lancet, which the excerpt notes was copied from this lineage, has become the reference case for what a cheap, mass-produced loitering munition can do to high-value targets when it is fielded in quantity and paired with decent reconnaissance. The Hero family and Lancet share a conceptual ancestry, which is why the copy is not incidental: it tells you the design logic is sound and that the competitive pressure is now about production rate, cost per round, and autonomy quality rather than airframe novelty.
Premium assessment
This forward assessment and the rest of the analysis belong to the Premium tier — available soon. Join the list on the Premium page and read it at launch.
Estonian AI firm's Neocortex enables EW-proof navigation and targeting as Uvision's $982M U.S. Army contract localizes Hero 120 production in America